Results 71 to 80 of about 36,016 (212)

Prediction of efficacy of lamivudine therapy for chronic type B liver diseases : studies based on changes in HBV-DNA amount and YMDD motif

, 2007
Lamivudine 100mg/日を経口投与し,1年以上の観察が可能であったB型慢性肝炎4例および非代償性肝硬変1例の計5例を対象とし,変異ウイルスの出現頻度および変異のパターンと臨床経過の関連について検討した.対象の内訳は全例男性,平均年齢は55.0±6.9歳(47～65歳),平均観察期間は39.0±15.5ヵ月である.治療前のHBV-DNA量は5.8～6.9LGE/mL,ALT値は33～471IU/Lに分布し,HBe抗原陽性は肝硬変の1例のみで,genotypeは全例Cであった ...
Ooe, Sayaka, Nakakarumai, Chihoko, 3049, 3048, 3047, 3046, 3045, Matsumoto, Chie, Ishikawa, Kazuyoshi, Isobe, Naoko   +9 more
core  

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

Infection and Drug Resistance, 2019
Xiaoning Wu,1–3,* Jialing Zhou,1–3,* Wen Xie,4 Huiguo Ding,5 Xiaojuan Ou,1–3 Guofeng Chen,6 Anlin Ma,7 Xiaoyuan Xu,8 Hui Ma,9 Youqing Xu,10 Xiaoqing Liu,11 Tongtong Meng,1–3 Lin Wang,1–3 Yameng Sun,1–3 Bingqiong Wang,1&
Wu X, Zhou J, Xie W, Ding H, Ou X, Chen G, Ma A, Xu X, Ma H, Xu Y, Liu X, Meng T, Wang L, Sun Y, Wang B, Kong Y, Ma H, You H, Jia J   +18 more
doaj  

Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations

Memorias do Instituto Oswaldo Cruz, 2006
Hepatitis B virus (HBV) molecular profiles were determined for 44 patients who were infected with human immunodeficiency virus (HIV) type 1 and had antibodies to the hepatitis B core antigen (anti-HBc), with and without other HBV serological markers.
Michel VF Sucupira, Francisco CA Mello, Eneida A Santos, Christian Niel, Valeria C Rolla, Juçara Arabe, Selma A Gomes   +6 more
doaj   +1 more source

Acute Syphilitic Posterior Placoid Chorioretinitis and Syphilitic Optic Neuropathy in a Patient With Human Immunodeficiency Virus Co‐Infection

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Syphilis is a re‐emerging global public health concern; recently, its incidence has significantly increased in all demographic groups. However, acute syphilitic posterior placoid chorioretinitis (ASPPC) and syphilitic optic neuropathy in a patient with human immunodeficiency virus (HIV) co‐infection are extremely uncommon.
Shengsheng Liu, Yuanyuan Zhang, Xiaogui Zhao, Bangtao Yao   +3 more
wiley   +1 more source

Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection

, 2003
Liver-related mortality is an increasing problem in human immunodeficiency virus (HIV)/hepatitis B virus (HBV)-coinfected patients receiving highly active antiretroviral therapy (HAART).
Gilson, RJ, Maini, MK, Bertoletti, A, Lascar, RM, Lopes, AR   +4 more
core  

Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.

, 2004
BACKGROUND/AIMS: Lamivudine efficiently inhibits hepatitis B virus replication and has been used to treat hepatitis B virus recurrence after orthotopic liver transplantation.
Campo N, Martelli A, PELLI N., Torre F, PICCIOTTO, ANTONINO, Mattioli F, CAMPO N., MARTELLI, ANTONIETTA MARIA, BASSO, MONICA, BASSO M., TORRE, FRANCESCO, MATTIOLI, FRANCESCA, Pelli N, Picciotto A., DELFINO A., Delfino A   +15 more
core   +1 more source

Abnormal coagulation profile in people living with HIV-AIDS on combined Antiretroviral Therapy: findings from a case-control study in the Ho municipality, Ghana

The Pan African Medical Journal, 2018
INTRODUCTION: Although combined Anti-Retroviral Therapy (cART) has improved the quality of life and survival in people living with HIV-AIDS (PLWHA), there have been reports of increased non-AIDS related co-morbidities such as coagulopathies.
Richard Kobina Dadzie Ephraim, James Elikem Ahadzie, Patrick Adu, Joseph Boachie, Hope Agbodzakey, Prince Adoba, Obed Cudjoe   +6 more
doaj   +1 more source

Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254]

, 2008
Patients with chronic hepatitis B virus (HBV) infection have a substantial risk of reactivation and jaundice following the use of immunosuppressant therapy.
Pol, Stanislas, Hayes, Peter C, Mills, Peter R, Carman, William, Mutimer, David, Barclay, Stephen, Benhamou, Yves, Cameron, Sheila   +7 more
core  

Unusual case of lamivudine-associated skin rashes in an HIV/AIDS patient: a case presentation

Archives of Pharmacy Practice, 2017
In patients with human immunodeficiency virus (HIV) infection, lamivudine is used as a first-line drug for antiretroviral therapy. Lamivudine is relatively nontoxic in nature, and it can also be used during pregnancy.
Kashif U Khan, Amer H Khan, Syed A Sulaiman, Chow T Soo, Syed I Ahmad   +4 more
doaj   +1 more source

Optimizing Identification and Care of Pregnant/Breastfeeding Women Living With HIV in Resource‐Limited Settings

Journal of the International AIDS Society, Volume 29, Issue S1, June 2026.
ABSTRACT Introduction Since the mid‐1990s, there have been major advances in diagnosing and providing antiretroviral therapy (ART) for pregnant women living with HIV (WLWH) in both resource‐rich and resource‐limited settings. Initial progress was based on the 1994 landmark perinatal trial, which showed 67% reduction in vertical transmission among ...
Mary Glenn Fowler, Victoria B. Chou, Philippa Musoke   +2 more
wiley   +1 more source